Evidence map›Paper›PMID 38947964›Full record

ArticleWorld journal of transplantation2024

Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation.

Sophia Hatzianastasiou, Paraskevas Vlachos, Georgios Stravopodis, Dimitrios Elaiopoulos, Afentra Koukousli, Josef Papaparaskevas, Themistoklis Chamogeorgakis, Kyrillos Papadopoulos, Theodora Soulele, Despoina Chilidou and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Stewardship of Molecular Diagnostics in Transplant Viral Infections.Transplant infectious disease : an official journal of the Transplantation Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sophia HatzianastasiouMicrobiology Department and Infection Control Office, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Paraskevas VlachosHeart Transplantation Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Georgios StravopodisMicrobiology Department and Infection Control Office, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Dimitrios ElaiopoulosCardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Afentra KoukousliMicrobiology Department and Infection Control Office, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Josef PapaparaskevasMicrobiology Department and Infection Control Office, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Themistoklis ChamogeorgakisHeart Transplantation Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Kyrillos PapadopoulosCardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Theodora SouleleCardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Despoina ChilidouHeart Transplantation Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Kyriaki KolovouCardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Aggeliki GkouzioutaHeart Transplantation Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Michail BoniosHeart Transplantation Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Stamatios AdamopoulosHeart Transplantation Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece.
Stavros DimopoulosCardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens 17674, Greece. stdimop@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransplant recipients commonly harbor multidrug-resistant organisms (MDROs), as a result of frequent hospital admissions and increased exposure to antimicrobials and invasive procedures.

aimTo investigate the impact of patient demographic and clinical characteristics on MDRO acquisition, as well as the impact of MDRO acquisition on intensive care unit (ICU) and hospital length of stay, and on ICU mortality and 1-year mortality post heart transplantation.

methodsThis retrospective cohort study analyzed 98 consecutive heart transplant patients over a ten-year period (2013-2022) in a single transplantation center. Data was collected regarding MDROs commonly encountered in critical care.

resultsAmong the 98 transplanted patients (70% male), about a third (32%) acquired or already harbored MDROs upon transplantation (MDRO group), while two thirds did not (MDRO-free group). The prevalent MDROs were

conclusionFollowing heart transplantation, a predominance of Gram-negative MDROs was noted. MDRO acquisition was associated with higher complication rates, prolonged ICU and total hospital stay, and higher post-transplantation mortality.

Indexed as

Heart transplantationMulti drug resistant organismsTransplantation complicationsTransplantation outcome

Identifiers

PMID38947964
PMCPMC11212582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.